Reini Juhani Hurme
Algemeen Directeur bij Zora Biosciences Oy
Actieve functies van Reini Juhani Hurme
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Algemeen Directeur | 14-12-2006 | - |
Oprichter | 14-12-2006 | - |
Loopbaan van Reini Juhani Hurme
Eerdere bekende functies van Reini Juhani Hurme
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Schering Oy | Corporate Officer/Principal | - | - |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Finland | 4 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Health Technology |
Schering Oy |
- Beurs
- Insiders
- Reini Juhani Hurme
- Ervaring